Transnational Cannabis Ltd.

OTC: TRCNF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 28

v0.1 · 5/100 weight · pillars only

↑ balance-sheet leverage, Altman-Z · ↓ Piotroski F, disclosure history

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$46.1M

Employees

—

Market cap

$29.6k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$00 CAD2018

Net income-$46.1M-60.3M CAD2018

Operating income-$31.7M-41.5M CAD2018

Total assets$53.0M69.8M CAD2018

Liabilities$5.3M6.9M CAD2018

Equity$47.7M62.8M CAD2018

Revenue trend

FY2016 – FY2018 · USD

FY16

FY17

FY18

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Transnational Cannabis Ltd. booked $0 in FY2018 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Spencer Pharmaceutical Inc.——Quick-Med Technologies, Inc.——Pressure BioSciences, Inc.——Braxia Scientific Corp.——

Key facts

CEODavid Shpilt

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: TRCNF

Employees—

IPO date2018-08-28

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.